2021.09.01 – The Cutting Edge of Mild Traumatic Brain Injury (mTBI): Providing an Objective Assessment to Brain Injury Evaluation Using Biomarkers (Recorded Webinar)
A Robert Sbordone Memorial mTBI/Concussion Lecture recorded webinar featuring Jeff Bazarian, M.D., M.P.H., Paul Jarvis, M.D., and Jesse M. Pines, M.D.
If you select "Add to Basket" below, you will be prompted to continue to payment. When you have completed the checkout process, you will receive an email with further instructions. The file contained in this email also includes instructions for receiving your ACBIS CEU.
Aired live September 1, 2021. Includes 1 ACBIS CEU.
Traumatic brain injury (TBI) is evaluated during ~5 million ED visits annually1 of which more than 80% are classified as mild (GCS 13 to 15)2. Due to the limitations of current evaluation tools, mTBI assessment can be time- and resource-consuming.
In this webinar, leading experts discuss the latest research into blood-based biomarkers and their potential to predict the absence of intracranial injury. You’ll also hear how two proteins, Ubiquitin C-terminal hydrolase-L1 (UCH-L1) and Glial fibrillary acidic protein (GFAP), have emerged as promising biomarkers that can be used in conjunction with other clinical information to aid in the evaluation of suspected mTBI patients in the ED.
- Examine challenges and shortcomings of the current approaches to mTBI evaluation in the ED
- Understand the latest advancements in TBI biomarkers, including identifying brain-specific biomarkers with characteristics that offer diagnostic value in the ED
- Understand how blood-based biomarker testing can be used in conjunction with other clinical information to aid in the evaluation of suspected mTBI patients
- Learn how blood-based biomarker testing in the ED can reduce diagnostic uncertainty by providing a quantifiable objective assessment to inform the evaluation of suspected mTBI
- Examine the potential for biomarker testing to reduce unnecessary head CT, improve patient care and satisfaction, and improve operational efficiency
Jeffrey J. Bazarian, M.D., M.P.H.
Professor of Emergency Medicine, University of Rochester School of Medicine
Paul Jarvis, M.D.
Emergency Medicine Physician, Director of Global Medical Affairs, Abbott Point of Care
Jesse M. Pines, M.D., M.B.A., M.S.C.E.
National Director of Clinical Innovation, U.S. Acute Care Solutions and Professor of Emergency Medicine, Drexel University
Korley FK et al. J Head Trauma Rehabil. 2016;31(6):379-387.
Dewan MC et al. J Neurosurg. 2004;43(suppl):113-125.